| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |